ard GA. Interventionalistâ€™s role in identifying candidates for
secondary fistulas. Semin Dial 2004;17:233-6.
108. Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol 1997;48:114-7.
109. Ponikvar R. Surgical salvage of thrombosed arteriovenous fistulas and
grafts. Ther Apher Dial 2005;9:245-9.
110. Palmer RM, Cull DL, Kalbaugh C, Carsten CG, Taylor SM, Snyder
BA, et al. Is surgical thrombectomy to salvage failed autogenous
arteriovenous fistulae worthwhile? Am Surg 2006;72:1231-3.
111. Bakken AM, Galaria II, Agerstrand C, Saad WE, Surowiec SM, Singh
MJ, et al. Percutaneous therapy to maintain dialysis access successfully

JOURNAL OF VASCULAR SURGERY
Volume 48, Number 5S

prolongs functional duration after primary failure. Ann Vasc Surg
2007;21:474-80.
112. Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning
arteriovenous fistula. Am J Kidney Dis 1999;33:910-6.
113. Bush RL, Lin PH, Lumsden AB. Management of thrombosed dialysis
access: thrombectomy versus thrombolysis. Semin Vasc Surg 2004;17:
32-9.
114. Sofocleous CT, Cooper SG, Schur I, Patel RI, Iqbal A, Walker S.
Retrospective comparison of the Amplatz thrombectomy device with
modified pulse-spray pharmacomechanical thrombolysis in the treatment of thrombosed hemodialysis access grafts. Radiology 1999;213:
561-7.
115. Dahm JB, Ruppert J, Doerr M, Bordihn N, Maybauer W. Percutaneous laser-fac